Pain Relief with Short Term Irradiation in Locally Advanced Carcinoma of the Pancreas

Journal of Palliative Care

Volumn 19, Issue 4, 2003, Pages 258-262

  Morganti, Alessio G ^a   Trodella, Lucio ^b   Valentini, Vincenzo ^b   Barbi, Sergio ^b   Macchia, Gabriella ^a   Mantini, Giovanna ^b   Turriziani, Adriana ^b   Cellini, Numa ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; MALE; PAIN; PAIN ASSESSMENT; PANCREAS CANCER; PATIENT SELECTION; PERCUTANEOUS SPLANCHNICECTOMY; RADIATION DOSE; RADIATION RESPONSE; REDUCTION; SCORING SYSTEM; SURGICAL TECHNIQUE;

EID: 1642555696     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585970301900407     Document Type: Article

References (22)

1. Russell RCG. Palliation of pain and jaundice: an overview. Ann Oncol 1999; 10: S165-S169.
2. Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer 1996; 78: 639-653.
3. Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CH, Schneider CJ, Rauws, et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 2000; 89: 2222-2229.
4. Minsky BD, Hilaris BS, Fuks Z. The role of radiation therapy in the control of pain from pancreatic carcinoma. J Pain Symptom Manage 1988; 3: 199-205.
5. Ishikawa H, Suzuki Y, Nakayama Y, Nakamoto S, Kusaba T, Kakinuma S, et al. Intraoperative radiotherapy and bypass surgery for unresectable pancreatic cancer. Hepatogastroenterology 2000; 47: 1151-1155.
6. Kawamura M, Kataoka M, Fujii T, Itoh H, Ishine M, Hamamoto K, et al. Electron beam intraoperative radiation therapy (EBIORT) for localized pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1992; 23: 751-757.
7. Moertel CG, Frytak S, Hanh RG, O'Connell MJ, Reitemeier RJ, Rubin, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-Fluorouracil) and high dose radiation + 5-Fluorouracil. Cancer 1981; 48: 1705-1710.
8. Gastrointestinal Tumour Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988; 80: 751-755.
9. Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, et al. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 2001; 29: 9-18.
10. Morganti AG, Trodella L, Valentini V, Doglietto GB, Ziccarelli P, Macchia G, et al. Preoperative radiochemo-therapy in pancreatic cancer: preliminary results. Tumori 1999; 85(1 suppl 1): S27-S32.
11. Macchia G, Smaniotto D, Costamagna G, Morganti AG, Trodella L, Mutignani M, et al. Concomitant chemoradiation in unresectable pancreatic cancer: impact on survival in 85 patients [abstract]. Radiother Oncol 2000; 56: S173, 2000.
12. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW (eds). Principles and practices of radiation oncology. Philadelphia: Lippincott Co., 1992; pp. 1-63
13. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
14. Sharfman WH, Walsh TD. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain 1990; 41: 267-271.
15. Ishe I, Borch K, Larsson J. Chronic pancreatitis: results of operations for relief of pain. World J Surg 1990; 14: 52-58.
16. Andren-Sandberg A, Viste A, Horn A, Hoem d, Gislason H. Pain management of pancreatic cancer. Ann Oncol 1999: 10(suppl 4): S265-S268
17. Modolell I, Guarner L, Malagelada JR. Vagaries of clinical presentation of pancreatic and biliary tract cancer. Ann Oncol 1999; 10: S82-S84.
18. Cellini N, Costamagna G, Morganti AG, Valentini V, Macchia G, Mutignani M, et al. Concomitant radiochemotherapy in unresectable carcinoma of the exocrine pancreas: cost-effectiveness analysis. Rays 1999; 24: 447-452.
19. Burris HA, Moore MJ, Andersen J, Green MR, Rothemberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-2413.
20. Dunst J, Reese T, Sutter T, Zuhlke H, Hinke A, Kolling-Schlebusch K, Frings S. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol; 2002; 2019: 3983-3991.
21. Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, Levin KJ, Shields AF. A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys; 2002; 53(3): 675-679.
22. Cartwright TH, Cohn A, Varkey JA, Chen YM, Szatrowski TP, Cox JV, Schulz JJ. Phase II study of oral capecitabine patients with advanced or metastatic pancreatic cancer. J Clin Oncol; 2002; 20(1): 160-164.